111 Capital Cuts Stake in Danaher Corporation $DHR

111 Capital lowered its holdings in shares of Danaher Corporation (NYSE:DHR) by 78.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,287 shares of the conglomerate’s stock after selling 4,621 shares during the period. 111 Capital’s holdings in Danaher were worth $255,000 as of its most recent filing with the SEC.

Several other institutional investors have also added to or reduced their stakes in the business. WFA of San Diego LLC bought a new stake in Danaher in the second quarter valued at approximately $26,000. Howard Hughes Medical Institute purchased a new position in shares of Danaher in the second quarter worth $27,000. ANTIPODES PARTNERS Ltd purchased a new position in shares of Danaher in the third quarter worth $27,000. TruNorth Capital Management LLC bought a new stake in Danaher during the 3rd quarter valued at $28,000. Finally, Tripletail Wealth Management LLC purchased a new stake in Danaher during the 3rd quarter valued at $31,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

DHR stock opened at $204.74 on Thursday. The stock’s 50 day simple moving average is $223.81 and its 200 day simple moving average is $216.12. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $242.80. The stock has a market capitalization of $144.78 billion, a PE ratio of 40.62, a price-to-earnings-growth ratio of 2.76 and a beta of 0.93.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. The business had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.14 EPS. As a group, research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, March 27th. This is a positive change from Danaher’s previous quarterly dividend of $0.32. Danaher’s payout ratio is presently 25.40%.

Wall Street Analyst Weigh In

A number of research firms have commented on DHR. HSBC upped their price target on Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research report on Monday, December 1st. Jefferies Financial Group upped their target price on Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Argus set a $265.00 price target on shares of Danaher in a report on Wednesday, January 14th. Wells Fargo & Company upped their price objective on shares of Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $253.86.

Insider Activity at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 11.10% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.